ClinicalTrials.gov
ClinicalTrials.gov Menu

Preeclampsia and Circulating Biomarkers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02136667
Recruitment Status : Unknown
Verified May 2014 by University of Aarhus.
Recruitment status was:  Recruiting
First Posted : May 13, 2014
Last Update Posted : January 6, 2015
Sponsor:
Collaborators:
Randers Regional Hospital
Karen Elise Jensen Foundation
Central Denmark Region
Information provided by (Responsible Party):
University of Aarhus

Brief Summary:

In order to assess circulating biomarkers of cardiovascular risk, we will conduct a 10-year follow-up study comparing 32 exposed (women with a history of pregnancy complicated by preeclampsia) and 32 unexposed (women with a history of uncomplicated pregnancy).

Participants will be recruited from a well-characterised cohort, previously assembled during their pregnancies, at the Department of Obstetrics at Randers Regional Hospital in 2001-2004.

Blood and urine samples, collected during their pregnancies, are stored in a biobank, thus rendering the possibility of longitudinal assessment.


Condition or disease
Postpartum CVD Risk in Women With Previous Preeclampsia.

Study Type : Observational
Estimated Enrollment : 64 participants
Observational Model: Cohort
Time Perspective: Retrospective
Study Start Date : April 2014
Actual Primary Completion Date : December 2014
Estimated Study Completion Date : December 2015

Resource links provided by the National Library of Medicine


Group/Cohort
Exposed
Women with a history of preeclampsia 10 years ago
Unexposed
Women with a history of uncomplicated pregnancy 10 years ago



Primary Outcome Measures :
  1. Circulating biomarkers of cardiovascular disease 10 years postpartum. [ Time Frame: 10 years postpartum ]

Secondary Outcome Measures :
  1. Markers of arteriosclerosis and atherosclerosis [ Time Frame: 10 years postpartum ]
  2. Circulating biomarkers of cardiovascular disease at baseline pregnancy. [ Time Frame: During pregnancy ]

Biospecimen Retention:   Samples With DNA
Blood serum Blood plasma Urine


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Participants will be recruited from a well-characterised cohort, previously assembled at the Department of Obstetrics at Randers Regional Hospital in 2001-2005.
Criteria

Inclusion Criteria:

  • Participation in previous study 2001-2005.

Exclusion Criteria:

  • Current pregnancy or breastfeeding

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02136667


Locations
Denmark
Randers Regional Hospital Recruiting
Randers, Randers NØ, Denmark, 8930
Contact: Martin Christensen, MD    004578422354    marticis@rm.dk   
Principal Investigator: Martin Christensen, MD         
Sponsors and Collaborators
University of Aarhus
Randers Regional Hospital
Karen Elise Jensen Foundation
Central Denmark Region
Investigators
Study Chair: Ulla B Knudsen, Professor Department of Obstetrics and Gynaecology, Aarhus University Hospital
Principal Investigator: Martin Christensen, MD Clinical Research Unit, Randers Regional Hospital
Study Director: Camilla S Kronborg, MD, PhD Department of Oncology, Aarhus University Hospital

Responsible Party: University of Aarhus
ClinicalTrials.gov Identifier: NCT02136667     History of Changes
Other Study ID Numbers: 98372017
First Posted: May 13, 2014    Key Record Dates
Last Update Posted: January 6, 2015
Last Verified: May 2014

Keywords provided by University of Aarhus:
Preeclampsia
Cardiovascular disease (CVD) risk

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications